Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

2012

4257 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Xanthine Derivatives

2020 Jul 18. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

0

0

0

PUBMED

Atomoxetine Therapy and CYP2D6 Genotype

Dean L.

2015 Sep 10 [updated 2020 Jun 29]. In: Pratt VM, McLeod HL, Rubinstein WS, Scott SA, Dean LC, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

0

0

0

PUBMED

Metabolic effects of aripiprazole and pimozide in children with Tourette syndrome.

Rizzo R, Eddy CM, Calí P, Gulisano M, Cavanna AE.

Pediatr Neurol. 2012 Dec;47(6):419-22. doi: 10.1016/j.pediatrneurol.2012.08.015.

0

0

0

PUBMED

Genetics of essential tremor.

Jasinska-Myga B, Wider C.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S138-9. doi: 10.1016/S1353-8020(11)70043-8. Review.

0

0

0

PUBMED

The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

Piquet AL, Venkiteswaran K, Marupudi NI, Berk M, Subramanian T.

Brain Res Bull. 2012 Jul 1;88(4):320-31. doi: 10.1016/j.brainresbull.2012.03.001. Review.

0

0

0

PUBMED

Neurocognitive correlates of apathy and anxiety in Parkinson's disease.

Bogdanova Y, Cronin-Golomb A.

Parkinsons Dis. 2012;2012:793076. doi: 10.1155/2012/793076.

0

0

0

PUBMED

Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease.

Rochester L, Yarnall AJ, Baker MR, David RV, Lord S, Galna B, Burn DJ.

Brain. 2012 Sep;135(Pt 9):2779-88. doi: 10.1093/brain/aws207.

0

0

0

PUBMED

Mutant huntingtin impairs immune cell migration in Huntington disease.

Kwan W, Träger U, Davalos D, Chou A, Bouchard J, Andre R, Miller A, Weiss A, Giorgini F, Cheah C, Möller T, Stella N, Akassoglou K, Tabrizi SJ, Muchowski PJ.

J Clin Invest. 2012 Dec;122(12):4737-47. doi: 10.1172/JCI64484.

0

0

0

PUBMED

A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease.

Beeler JA, Frank MJ, McDaid J, Alexander E, Turkson S, Bernardez Sarria MS, McGehee DS, Zhuang X.

Cell Rep. 2012 Dec 27;2(6):1747-61. doi: 10.1016/j.celrep.2012.11.014. Erratum in: Cell Rep. 2014 Jul 24;8(2):646. Bernandez, Maria Sol [corrected to Bernardez Sarria, Maria Sol].

0

0

0

PUBMED

The pattern of cortical atrophy in Parkinson's disease with mild cognitive impairment according to the timing of cognitive dysfunction.

Lee JE, Cho KH, Kim M, Sohn YH, Lee PH.

J Neurol. 2012 Mar;259(3):469-73. doi: 10.1007/s00415-011-6203-x.

0

0

0

PUBMED

Intracerebroventricular transplanted bone marrow stem cells survive and migrate into the brain of rats with Parkinson's disease.

Gu P, Zhang Z, Cui D, Wang Y, Ma L, Geng Y, Wang M.

Neural Regen Res. 2012 May 5;7(13):978-84. doi: 10.3969/j.issn.1673-5374.2012.13.003.

0

0

0

PUBMED

[Diagnosis of dopa-responsive dystonia after 34 years: complete remission after L-dopa treatment].

Reichel G, Stenner A.

Nervenarzt. 2012 Jun;83(6):772-4. doi: 10.1007/s00115-011-3423-3. German. No abstract available.

0

0

0

PUBMED

Movement preparation and cortical processing of afferent inputs in cortical tremor: an event-related (de)synchronization (ERD/ERS) study.

Houdayer E, Degardin A, Salleron J, Bourriez JL, Defebvre L, Cassim F, Derambure P.

Clin Neurophysiol. 2012 Jun;123(6):1207-15. doi: 10.1016/j.clinph.2011.10.043.

0

0

0

PUBMED

Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.

Rampersaud N, Harkavyi A, Giordano G, Lever R, Whitton J, Whitton PS.

Neuropeptides. 2012 Oct;46(5):183-93. doi: 10.1016/j.npep.2012.07.004. Retraction in: Neuropeptides. 2013 Jun;47(3):221.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy